Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by SouthernTierTomon Mar 16, 2022 2:40pm
96 Views
Post# 34519363

RE:RE: Is the CTSO "XL" product still going to eliminate PMX need?

RE:RE: Is the CTSO "XL" product still going to eliminate PMX need?BOLD statement ... AND "unchallenged"

Tell me, mirror mirror on the wall ... "has the XL ever been used on a human at all"?

And the detail promptly delivered by our good friend the "economist" at an AGM .... "Indeed Doc, John is our friend"....but ultimately a BIG FAN of PMX and now a shareholder near as LARGE as you!  Free dessert for ALL those on their way to the Merry Land.

INDEED ... let the "Beech Boys" continue to "work the bored" ...

A little too easy for the average bear to figger out....good thing...Peter Falk passed years ago! ; - )


In a head-to-head comparison with the leading endotoxin adsorber, Toraymyxin™ (Toray, Japan), CytoSorb-XL matched the level of endotoxin reduction in an in vitro plasma recirculation system on a comparable volume basis.  CytoSorb-XL is expected to eliminate the need for stand-alone endotoxin specific filters by offering superior performance in the removal of not just endotoxin, but a much broader array of inflammatory mediators that drive uncontrolled deadly inflammation, organ failure, and death in sepsis
<< Previous
Bullboard Posts
Next >>